Tradestie Institutional Equity Comparison Engine
MLTX vs WVE โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
MLTX Overall Edge
MLTX Captures Institutional Edge (3โ0 Pillars ยท 4โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, MLTX trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus WVE at N/M Forward P/E and -320.9% operating margin (+73.0% YoY). In options structure, MLTX sits in BREAKDOWN (7th %ile IV; Dealer Gamma Walls on Pro) against WVE sits in BREAKDOWN (62nd %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
MLTX N/M vs WVE N/M Fwd P/E
Growth & Margin Winner
MLTX
Op Margin 0.0% vs -320.9% ยท YoY +0.0% vs +73.0%
Momentum & Technical Winner
MLTX
1Y -5.7% vs -56.8% ยท 52W Pos 17% vs 0%
Options & Structure Winner
MLTX
BREAKDOWN (7th %ile IV) vs BREAKDOWN (62nd %ile IV)
MLTX
NASDAQ
MoonLake Immunotherapeutics Class A Ordinary Shares
Pharmaceutical Preparations
$11.85
-5.2% 1D
Market Cap
$1.1B
1M Return
+24.08%
1Y Return
-5.65%
Forward P/E
N/M
Unified AI Score
38.3 / 100
SELL
Tech 32.0
Fund 44.0
Flow 75.0
Mom 50.0
WVE
NASDAQ
Wave Life Sciences Ltd. Ordinary Shares
Pharmaceutical Preparations
$2.89
-7.82% 1D
Market Cap
$621.3M
1M Return
-7.82%
1Y Return
-56.75%
Forward P/E
N/M
Unified AI Score
41.5 / 100
SELL
Tech 21.0
Fund 46.0
Flow 68.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
MLTX -5.65%
WVE -56.75%
Spread: +51.1 pp (MLTX Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
MLTX TTM Op. Margin: 0.0%
WVE TTM Op. Margin: -320.9%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MLTX vs WVE. Trailing 12-month operating profitability (MLTX 0.0% vs WVE -320.9%) and valuation multiples (MLTX N/M vs WVE N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | MLTX | WVE | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.1B | $621.3M | Larger Scale | MLTX |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +0.0% | +73.0% | Higher Growth | WVE |
| Operating Margin (TTM) Profitability | 0.0% | -320.9% | Higher Margin | MLTX |
| Net Profit Margin Profitability | 0.0% | -296.9% | Higher Margin | MLTX |
| Return on Equity (ROE) Capital Efficiency | -81.5% | -78.8% | Higher ROE | WVE |
| 52-Week Range Position Momentum | 17% ($9โ$23) | 0% ($3โ$21) | Stronger Trend | MLTX |
| Beta / 30D Volatility Risk Regime | 1.61ฮฒ ยท 90% Vol | 1.94ฮฒ ยท 76% Vol | Lower Realized Risk | WVE |
| Unified Institutional Score Composite Signal | 38.3 / 100 (SELL) | 41.5 / 100 (SELL) | Higher Composite | WVE |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full MLTX vs WVE Buy Guide
MLTX
BREAKDOWN
103d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
7th %ile
IV Regime
Compressed (<25th %ile)
WVE
BREAKDOWN
149d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
62nd %ile
IV Regime
Elevated (60thโ80th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither MLTX nor WVE registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.